A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

Autor: Scagliotti, Giorgio Vittorio, Smit, E, Bosquee, L, O'Brien, M, Ardizzoni, A, Zatloukal, P, Eberhardt, W, Smid Geirnaerdt, M, de Bruin HG, Dussenne, S, Legrand, C, Giaccone, G, European Organisation for Research, Treatment of Cancer Lung Cancer Group

Publikováno v: Lung Cancer, 50(1), 91-96. Elsevier Ireland Ltd
Scagliotti, GV, Smit, E F, Bosquee, L, O'Brien, M, Ardizzoni, A, Zatloukal, P, Eberhardt, W, Smid-Geirnaerdt, M, de Bruin, H G, Dussenne, S, Legrand, C & Giaccone, G 2005, ' A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956) ', Lung Cancer, vol. 50, no. 1, pp. 91-96 . https://doi.org/10.1016/j.lungcan.2005.05.012

Purpose: The incidence of bronchioloalveolar carcinoma (BAC) has risen steadily over the last decades along with the increasing frequency of adenocarcinomas. BAC is relatively resistant to commonly used chemotherapy regimens. A phase 11 study with si

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea65d55a2b4b205b3edea567440899b
https://doi.org/10.1016/j.lungcan.2005.05.012

EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)

Autor: Ardizzoni, A., Manegold, C., Debruyne, C., Gaafar, R., Buchholz, E., Dussenne, S., Legrand, C., King, K., Giaccone, G.

Publikováno v: Lung Cancer; 2000, Vol. 29 Issue: 1 p51-51, 1p